Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patients

Potential effective treatment of shortening continuous erythropoietin receptor activator treatment interval combined with iron supplementation in hemodialysis patients

Our previous randomized controlled trial comparing the total dose of weekly versus biweekly continuous erythropoietin receptor activator (CERA) therapy to maintain optimal hemoglobin (Hb) levels showed no significant differences between the two therapies. This post-hoc analysis assessed whether the...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuki Kawai (Author), Yoshiyuki Toya (Author), Hiromichi Wakui (Author), Tetsuya Fujikawa (Author), Eiko Ueda (Author), Kengo Azushima (Author), Sho Kinguchi (Author), Hiroshi Mitsuhashi (Author), Tomoyuki Kawano (Author), Tadashi Kuji (Author), Satoshi Yamaguchi (Author), Toshimasa Ohnishi (Author), Kouichi Tamura (Author)
Format: Book
Published: Elsevier, 2021-09-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items